- Hepatitis viruses
- Human Immunodeficiency Virus
- Human T-Lymphotropic Virus
- Others
Blood Virus Testing Market was valued at USD 15,602.3 million in 2022 and is poised to grow at a CAGR of 6.4% from 2023 to 2029. Blood virus testing is a process of detecting viruses in blood samples. blood virus testing helps in identifying the virus-causing infection and to determine best treatment. Blood virus is useful in early detection of infections which can improve treatment outcomes. Increasing prevalence of blood borne viral infection such as hepatitis-B, C, HIV is expected to drive the blood virus testing market growth. The increasing incidence of viral infections are expected to increase the demand for accurate and reliable diagnostic tests to diagnose in early stages. In addition, increasing demand for blood and blood-derived products which are used for transfusion surgeries, and other medical procedures is expected to boost the growth of blood virus testing market as it is necessary to test for blood borne viral infections to prevent the transmission of viral infections.
Furthermore, the advancement in diagnostics and the development of new diagnostic tools and techniques such as nucleic acid testing and other diagnostic tests to improve the accuracy and timeliness of blood virus testing is expected to boost the growth of virus testing market at a significant rate over the forecast period. However, high cost associated with blood virus testing in developing countries along with limitation for current diagnostic technologies, especially in patients with low viral load and patients co-affected with multiple infection are expected to restraint the growth of blood virus testing market. Moreover, the growing focus on preventive healthcare and rising use of blood tests for early detection along with the technological advancement and innovation in diagnostics are anticipated to provide an opportunity to the market key players in the growth of blood virus testing market over the forecast period.
Blood Virus Testing Market Key Developments:
- In April 2020, Abbott launched the third Covid 19 test, a laboratory-based antibody test.
- In July 2020, researchers in prestigious Monash University in Melbourne have developed a new blood test to detect Covid 19 virus in 20 minutes.
Blood Virus Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.4%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Blood Virus Testing Market Dynamics
The blood virus testing market is expected to grow over the forecasted period due to the increasing prevalence of blood borne viral infections such as HIV, Hepatitis-C, B. these infections are transmitted through contaminated blood, body fluids, and tissues. Early diagnosis and treatment of viral infection are crucial to prevent transmission and disease progression. For instance, according to the World Health Organization, about 325 million people globally were living with hepatitis B and C in 2019. The rising burden of blood borne viral infection is expected to increase the demand for blood virus testing across the globe and drive the growth of blood virus testing market over the forecast period.
North America Got Highest Share
Blood Virus Testing Market Regional Analysis
The blood virus testing market is segmented based on regions into North America, Asia-pacific, Europe, Latin America, and the Middle East and Africa. The North America blood virus testing market is likely to hold a significant revenue share, and in the forecasted years, it is predicted to increase rapidly due to the presence of well-established healthcare infrastructure and increasing awareness among the people about the infection and treatment. Asia Pacific region is expected to be fastest growing region and expected to have highest CAGR over the forecast period owing to rising incidence of blood borne viral infections along with the improving healthcare infrastructures in developing countries like China, India, Japan.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Blood Virus Testing Market Segmentation
By Virus Type
By Test Type
- Full Blood Count Test
- Test for Inflammation
- Immunology Test
- Liver Function Test
- Others
By End User
- Hospitals
- Diagnostic Centers
- Clinics
- Ambulatory Surgical Centers
- Others
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
High cost of blood testing is expected to hinder the growth of blood virus testing market over the forecast period.
The leading players in the global Blood Virus Testing market are BioMérieux, Bio-Rad Laboratories, Abbott, Randox Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Omega Diagnostics Group, OraSure Technologies.
The Blood Virus Testing market is segmented based on Virus Type, Test Type, End User, and geography.
| 1.Executive Summary |
| 2.Global Blood Virus Testing Market Introduction |
| 2.1.Global Blood Virus Testing Market - Taxonomy |
| 2.2.Global Blood Virus Testing Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.Virus Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Blood Virus Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood Virus Testing Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Blood Virus Testing Market By Test Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Hepatitis viruses |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Human Immunodeficiency Virus |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Human T-Lymphotropic Virus |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Blood Virus Testing Market By Virus Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Full Blood Count Test |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Test for Inflammation |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Immunology Test |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Liver Function Test |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Blood Virus Testing Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Centers |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Clinics |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Ambulatory Surgical Centers |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Blood Virus Testing Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hepatitis viruses |
| 9.1.2.Human Immunodeficiency Virus |
| 9.1.3.Human T-Lymphotropic Virus |
| 9.1.4.Others |
| 9.2. Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Full Blood Count Test |
| 9.2.2.Test for Inflammation |
| 9.2.3.Immunology Test |
| 9.2.4.Liver Function Test |
| 9.2.5.Others |
| 9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic Centers |
| 9.3.3.Clinics |
| 9.3.4.Ambulatory Surgical Centers |
| 9.3.5.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hepatitis viruses |
| 10.1.2.Human Immunodeficiency Virus |
| 10.1.3.Human T-Lymphotropic Virus |
| 10.1.4.Others |
| 10.2. Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Full Blood Count Test |
| 10.2.2.Test for Inflammation |
| 10.2.3.Immunology Test |
| 10.2.4.Liver Function Test |
| 10.2.5.Others |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic Centers |
| 10.3.3.Clinics |
| 10.3.4.Ambulatory Surgical Centers |
| 10.3.5.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hepatitis viruses |
| 11.1.2.Human Immunodeficiency Virus |
| 11.1.3.Human T-Lymphotropic Virus |
| 11.1.4.Others |
| 11.2. Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Full Blood Count Test |
| 11.2.2.Test for Inflammation |
| 11.2.3.Immunology Test |
| 11.2.4.Liver Function Test |
| 11.2.5.Others |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic Centers |
| 11.3.3.Clinics |
| 11.3.4.Ambulatory Surgical Centers |
| 11.3.5.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hepatitis viruses |
| 12.1.2.Human Immunodeficiency Virus |
| 12.1.3.Human T-Lymphotropic Virus |
| 12.1.4.Others |
| 12.2. Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Full Blood Count Test |
| 12.2.2.Test for Inflammation |
| 12.2.3.Immunology Test |
| 12.2.4.Liver Function Test |
| 12.2.5.Others |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic Centers |
| 12.3.3.Clinics |
| 12.3.4.Ambulatory Surgical Centers |
| 12.3.5.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hepatitis viruses |
| 13.1.2.Human Immunodeficiency Virus |
| 13.1.3.Human T-Lymphotropic Virus |
| 13.1.4.Others |
| 13.2. Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Full Blood Count Test |
| 13.2.2.Test for Inflammation |
| 13.2.3.Immunology Test |
| 13.2.4.Liver Function Test |
| 13.2.5.Others |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic Centers |
| 13.3.3.Clinics |
| 13.3.4.Ambulatory Surgical Centers |
| 13.3.5.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.BioMérieux |
| 14.2.2.Bio-Rad Laboratories |
| 14.2.3.Abbott |
| 14.2.4.Randox Laboratories |
| 14.2.5.F. Hoffmann-La Roche |
| 14.2.6.Thermo Fisher Scientific |
| 14.2.7.Omega Diagnostics Group |
| 14.2.8.OraSure Technologies |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- BioMérieux
- Bio-Rad Laboratories
- Abbott
- Randox Laboratories
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Omega Diagnostics Group
- OraSure Technologies